We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Home-Based Treatment for Asthma

By HospiMedica staff writers
Posted on 25 Oct 2005
Children with asthma who received a new home-based environmental intervention program had 19% fewer unscheduled clinic visits, a 13% reduction in the use of albuterol inhalers, and 38 more symptom-free days over two years than children in a control group.

The home-based program targeted six major classes of allergens that trigger asthma symptoms: dust mites, cockroaches, pet dander, rodents, passive smoking, and mold. More...
Treatment was tailored to each child's sensitivity to the selected allergens and evidence of exposure to the specific triggers. During home visits, subjects were instructed on measures for reducing or eliminating allergen levels in the home. These included allergen-permeable covers on a mattress and pillows, air purifiers with particulate air (HEPA) filters, vacuum cleaners equipped with HEPA filters, and professional pest control.

"The findings of this study will enable policy makers and healthcare providers to more effectively allocate resources to achieve maximum benefits,” said Peter J. Gergen, M.D.. M.P.H., of the U.S. National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD, USA), which helped to fund the study.

The study's results showed that this treatment cost only about U.S.$27.57 per symptom-free day, as cost-effective as many drug interventions. Data also showed that the cost would be substantially lower if the interventions were implemented in a community setting. The study was published in the October 11, 2005, online issue of the Journal of Allergy and Clinical Immunology.




Related Links:
.S. National Institute of Allergy and Infectious Diseases

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Medical-Grade Display
HL2316SHTB
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.